<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="case-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">BMJ Case Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">BMJ Case Rep</journal-id>
<journal-id journal-id-type="hwp">casereports</journal-id>
<journal-id journal-id-type="publisher-id">bmjcasereports</journal-id>
<journal-title-group>
<journal-title>BMJ Case Reports</journal-title>
</journal-title-group>
<issn pub-type="epub">1757-790X</issn>
<publisher>
<publisher-name>BMJ Publishing Group</publisher-name>
<publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28108439</article-id>
<article-id pub-id-type="pmc">5256579</article-id>
<article-id pub-id-type="publisher-id">bcr-2016-218016</article-id>
<article-id pub-id-type="doi">10.1136/bcr-2016-218016</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
<subj-group subj-group-type="case-report-type">
<subject>Rare Disease</subject>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>1523</subject>
</subj-group>
<subj-group subj-group-type="search-fields">
<subject>Male</subject>
<subject>31-50 years</subject>
<subject>White</subject>
<subject>USA/Canada</subject>
</subj-group>
<series-title>Case Report</series-title>
</article-categories>
<title-group>
<article-title>De novo 2p16.1 microdeletion with metastatic esophageal adenocarcinoma</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-3197-0539</contrib-id>
<name>
<surname>Codipilly</surname>
<given-names>Don Chamil</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gavrilova</surname>
<given-names>Ralitza H</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tangalos</surname>
<given-names>Eric G</given-names>
</name>
<xref ref-type="aff" rid="af3">3</xref>
</contrib>
</contrib-group>
<aff id="af1">
<label>1</label><addr-line>Department of Internal Medicine</addr-line>, <institution>Mayo Clinic Minnesota</institution>, <addr-line>Rochester, Minnesota</addr-line>, <country>USA</country></aff>
<aff id="af2">
<label>2</label><addr-line>Department of Clinical Genomics and Neurology</addr-line>, <institution>Mayo Clinic Minnesota</institution>, <addr-line>Rochester, Minnesota</addr-line>, <country>USA</country></aff>
<aff id="af3">
<label>3</label><addr-line>Department of Primary Care Internal Medicine</addr-line>, <institution>Mayo Clinic Minnesota</institution>, <addr-line>Rochester, Minnesota</addr-line>, <country>USA</country></aff>
<author-notes>
<corresp><label>Correspondence to</label> Dr Eric G Tangalos, <email>tangalos@mayo.edu</email></corresp>
<fn fn-type="COI-statement">
<p><bold>Competing interests:</bold> None declared.</p>
</fn>
</author-notes>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>20</day>
<month>1</month>
<year>2017</year>
</pub-date>
<volume>2017</volume>
<elocation-id>bcr2016218016</elocation-id>
<history>
<date date-type="accepted">
<day>4</day>
<month>1</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>2017 BMJ Publishing Group Ltd</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<self-uri xlink:href="bcr-2016-218016.pdf" xlink:title="pdf"></self-uri>
<abstract>
<p>Microdeletions involving chromosome 2p15-16.1 are a rare genetic abnormality and have been reported in 18 separate patients, mainly children, since 2007. This microdeletion syndrome is characterised by a heterogeneous expression of intellectual impairment, dysmorphic facies, musculoskeletal abnormalities and potential neurodevelopmental anomalies. We report the first case of natural progression in an adult patient who died at a young age of metastatic esophageal adenocarcinoma. Important learning points include the variable phenotypic expression of this microdeletion syndrome and the fact that clinicians must be thorough in investigating objective discrepancies in patients who cannot endorse classical symptoms.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>